TY - JOUR
T1 - Initial clinical outcomes and prognostic variables in the implementation of a Code Sepsis in a high complexity University Hospital
AU - Ramasco, F
AU - Figuerola, A
AU - Mendez, R
AU - DR, Serrano
AU - von Wernitz, A
AU - Hernandez-Aceituno, A
AU - Saez, C
AU - Cardenoso, L
AU - Martin, E
AU - Garcia-Vazquez, N
AU - de las, Cuevas C
AU - Pascual, N
AU - Bautista, A
AU - Jimenez, D
AU - Fernandez, G
AU - Leal, A
AU - Vinuesa, M
AU - Pizarro, A
AU - DI MARTINO, MARCELLO
AU - Del, Campo L
AU - IG, Sanz
AU - Chicot, M
AU - Barrios, A
AU - MJ, Rubio
AU - HU, de La Princesa
N1 - Publisher Copyright:
© 2019, Sociedad Espanola de Quiminoterapia. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Objectives. To assess the impact of the first months of application of a Code Sepsis in a high complexity hospital, analyzing patient´s epidemiological and clinical characteristics and prognostic factors. Materials and methods. A long-term observational study was carried out throughout a consecutive period of seven months (February 2015 – September 2015). The relationship with mortality of risk factors, and analytic values was analyzed using uni-and multivariate analyses. Results. A total of 237 patients were included. The in-hospital mortality was 24% at 30 days and 27% at 60 days. The mortality of patients admitted to Critical Care Units was 30%. Significant differences were found between the patients who died and those who survived in mean levels of creatinine (2.30 vs 1.46 mg/dL, p <0.05), lactic acid (6.10 vs 2.62 mmol/L, p <0.05) and procalcitonin (23.27 vs 12.73 mg/dL, p <0.05). A statistically significant linear trend was found between SOFA scale rating and mortality (p<0.05). In the multivariate analysis additional independent risk factors associated with death were identified: age > 65 years (OR 5.33, p <0.05), lactic acid > 3 mmol/L (OR 5,85, p <0,05), creatinine > 1,2 mgr /dL (OR 4,54, p <0,05) and shock (OR 6,57, P <0,05). Conclusions. The epidemiological, clinical and mortality characteristics of the patients in our series are similar to the best published in the literature. The study has identified several markers that could be useful at a local level to estimate risk of death in septic patients. Studies like this one are necessary to make improvements in the Code Sepsis programs.
AB - Objectives. To assess the impact of the first months of application of a Code Sepsis in a high complexity hospital, analyzing patient´s epidemiological and clinical characteristics and prognostic factors. Materials and methods. A long-term observational study was carried out throughout a consecutive period of seven months (February 2015 – September 2015). The relationship with mortality of risk factors, and analytic values was analyzed using uni-and multivariate analyses. Results. A total of 237 patients were included. The in-hospital mortality was 24% at 30 days and 27% at 60 days. The mortality of patients admitted to Critical Care Units was 30%. Significant differences were found between the patients who died and those who survived in mean levels of creatinine (2.30 vs 1.46 mg/dL, p <0.05), lactic acid (6.10 vs 2.62 mmol/L, p <0.05) and procalcitonin (23.27 vs 12.73 mg/dL, p <0.05). A statistically significant linear trend was found between SOFA scale rating and mortality (p<0.05). In the multivariate analysis additional independent risk factors associated with death were identified: age > 65 years (OR 5.33, p <0.05), lactic acid > 3 mmol/L (OR 5,85, p <0,05), creatinine > 1,2 mgr /dL (OR 4,54, p <0,05) and shock (OR 6,57, P <0,05). Conclusions. The epidemiological, clinical and mortality characteristics of the patients in our series are similar to the best published in the literature. The study has identified several markers that could be useful at a local level to estimate risk of death in septic patients. Studies like this one are necessary to make improvements in the Code Sepsis programs.
UR - https://iris.uniupo.it/handle/11579/183648
M3 - Article
SN - 0214-3429
VL - 32
SP - 238
EP - 245
JO - Revista Espanola de Quimioterapia
JF - Revista Espanola de Quimioterapia
IS - 3
ER -